Aryl methyl ketones 1a-e gave with N,N-dimethylacetamide dimethylacetal (DMADMA) (E)-1-aryl-3-(dimethylamino)-but-2-en-1-ones 2a-e. Substitution of the N,N-(dimethylamino) group in the reaction with ammonium acetate afforded the corresponding (Z)-3-amino-1-aryl-but-2-en-1-ones 3a-e. In the reaction of 3a-e with diethyl azodicarboxylate intermediates 4a-e were formed, which were, in most cases without isolation, cyclized into ethyl (5-aroyl-4-methyl-2-oxo-2,3-dihydro-1H-imidazol-1-yl)carbamates 5a-e. Hydrolysis of the ester group, followed by the decarboxylation and deamination of intermediates 6a-c,e produced 4-aroyl-5-methyl-1H-imidazol-2(3H)-ones 7a-c,e.
Introduction
Nitrogen containing heterocycles 1 are of special interest in organic synthetic chemistry, since they occur in wide variety of natural products. The imidazolone motif appears in many natural products, 2 which possess interesting biological activities. 3 They are inhibitors of V-RAF murine sarcoma viral oncogene homologue B1. 4 They are antagonists of many receptors including the neurokinin-1 receptor 5 and the dopamine receptor. 6 They were applied as intermediates in the synthesis of many natural products, such as biotin, 7 slagenins, 8 axinohydantoins, 9 oroidin-derived alkaloids, 10 aplysinopsins, 11 Lancetta-derived alkaloid carcaridine A, 12 and others. Due to their importance many methods have been developed for construction of imidazole ring. 13, 14 Recently,
Figure 1. 5-Methyl-4-[4-(methylthio)benzoyl]-1H-imidazol-2(3H)-one (Perfan or Enoximone).
The wide applicability of 3-(dimethylamino)-propenoates and related enaminones as versatile reagents in heterocyclic synthesis, 21 parallel solution-phase and solid-phase synthesis of fused pyrimidinones, 22 and stereochemical synthesis, 23 including natural products and their analogues, e.g. the aplysinopsins, 24 meridianines, 25 dipodazines, 26 and triprostatines 27 has been demonstrated. Recently, a simple one-pot synthesis of ethyl 4-benzoyl-2-oxo-3-substituted-2,3-dihydro-1H-imidazol-1-yl)carbamates has been described. 28 In this communication we report a simple synthesis of ethyl (5-aroyl-4-methyl-2-oxo-2,3-dihydro-1H-imidazol-1-yl)carbamate followed by hydrolysis of the ester group, decarboxylation and deamination to give 4-aroyl-5-methyl-1H-imidazol-2(3H)-ones.
Results and Discussion
In this paper we report the preparation of 5-methyl-4-(aroyl substituted)imidazol-2(1H)-ones starting from aryl methyl ketones 1a-e, which were transformed by treatment with N,N-dimethyl acetamide dimethylacetal (DMADMA) into (E)-3-(dimethylamino)-1-(4-substituted-phenyl)but-2-en-1-ones 2a-e. These were treated with ammonium acetate to form (Z)-3-amino-1-(4-substituted-phenyl)but-2-en-1-ones 3a-e. By further reaction with diethyl azodicarboxylate (DEAD) intermediates 4a-e were formed which cyclize after addition of sodium hydroxide under experimental conditions into ethyl [5-aroyl-4-methyl-2-oxo-2,3-dihydro-1H-imidazol-1-yl]carbamates 5a-e. After hydrolysis of the ester group, followed by decarboxylation and deamination, 4-aroyl-5-methyl-1H-imidazol-2(3H)-ones 7a-c,e were isolated.
In our first attempt to synthesize 5-methyl-4-[(4-methylthio)benzoyl]-1H-imidazol-2(1H)-one (7a) (Enoximone or Perfan) we treated 1-[(4-methylthio)phenyl]ethanone (1a) with dimethylacetamide dimethylacetal (DMADMA) in dry toluene to afford (E)-3(dimethylamino)-[(4-methylthio)phenyl]but-2-en-1-one (2a) as an yellow oil in ~5 % yield. By further treatment of this compound with ammonium acetate in MeOH for 18 h at room temperature the corresponding (Z)-3-amino-1-[(4-methylthio)phenyl]but-2-en-1-one (3a) was obtained practically quantitatively as a yellow solid. In the reaction of 3a with diethyl azodicarboxylate (DEAD) in EtOH for 2 h at room temperature, without the isolation of the intermediate 4a, ethyl [4-methyl-5-(4-methylthio)benzoyl]-2-oxo-2,3-dihydro-1H-imidazol-1-yl]carbamate (5a) was isolated in 68 % yield upon addition of NaOH to 4a. At the end 5a was hydrolyzed and decarboxylated by heating at reflux temperature in an aqueous ethanolic KOH solution for 20 h to afford 1-amino-4-methyl--(4-methylthio)benzoyl)-1H-imidazol-2(3H)-one (6a) which was directly deaminated to 5-methyl-4-(4-(methylthio)benzoyl)-1H-imidazol-2(3H)-one (7a) in 93 % overall yield. However, the overall yield starting from 1a was very low (< 3%).
In order to avoid the extremely poor yield in the transformation of 1a into 2a, we extended the reaction to a number of aryl ketones 1b-f and prepared the corresponding analogues of enoximone 7a. (Scheme 1, Table 1 ). We found that 1-(4-fluorophenyl)ethanone (1f) could be transformed with DMADMA into (E)-3-(dimethylamino)-1-1(4-fluorophenyl)but-2-en-1-one (2f) in 67 % yield. The substitution of fluorine with MeSNa afforded (E)-3-(dimethylamino)-1-1-(4-(methylthio)phenyl)but-2-en-1-one (2a) in 80 % yield. In this way, following the reaction sequence 1f → 2f → 2a → 3a → 4a → 5a → 6a → 7a, the overall yield was 32 % (Scheme 2). 
Scheme 2
The structure of (E)-1-aryl-3-(dimethylamino)but-2-en-1-ones 2a-e is supported by X-ray analysis for compound 2d (Figure 2 ). The orientation around the double bond in compounds 2 and 3 was determined on the basis of chemical shifts. In compounds 2 the methyl group appear downfield (δ = 2.50-2.67 ppm) in comparison to the chemical shift of methyl group in compounds 3 (δ = 2.05-2.09 ppm). Furthermore, in (Z)-3-amino-1-aryl-but-2-en-1-ones (3) a large difference in chemical shifts (~5ppm) for both protons attached to the amino group was observed, due to the strong intramolecular hydrogen bond of one proton to carbonyl group ( Figure 2) . 
Conclusions
In summary, a new synthetic method for the preparation of 4-aroyl-5-methyl-1H-imidazol-2(3H)-ones (7a-c,e) (Enoximone analogues) was developed. The synthesis started with commercially available methyl ketones 1a-f which were transformed with DMADMA into (E)-1-aryl-3-(dimethylamino)-but-2-en-1-ones 2a-e. Substitution of the N,N-(dimethylamino) group with NH4OAc afforded the corresponding (Z)-3-amino-1-aryl-but-2-en-1-ones 3a-e. In the reaction of 3a-e with diethyl azodicarboxylate intermediates 4a-e were formed, which were cyclized into ethyl 5-aroyl-4-methyl-2-oxo-2,3-dihydro-1H-imidazol-1-yl)carbamates 5a-e. Hydrolysis of the ester group, followed by the decarboxylation and deamination of 1-amino-5-aroyl-4-methyl-1H-imidazol-2(3H)-ones 6a-c,e as intermediates produced 4-aroyl-5-methyl-1H-imidazol-2(3H)-ones 7a-c,e (Enoximone analogues).
Experimental Section
General. Melting points were determined on a Kofler micro hot stage and on a SRS OptiMelt MPA100-Automated Melting Point System. NMR spectra were obtained on a Bruker Avance DPX 300 at 300 MHz for 1 H and 75.5 MHz for 13 C, and a Bruker UltraShield 500 plus at 500 MHz for 1 H and 126 MHz for 13 C, using DMSO-d6 and CDCl3 with TMS as the internal standard, as solvents. Mass spectra were recorded on an AutoSpecQ spectrometer and Agilent 6224 Accurate Mass TOF LC/MS, IR spectra on a Perkin-Elmer Spectrum BX FTIR spectrophotometer. The microanalyses for C, H, and N were performed on a Perkin-Elmer CHN Analyser 2400 II. Column chromatography (CC) was performed on silica gel (Fluka, Silica gel 60, particle size: 0.035-0.070 mm).
(E)-3-(Dimethylamino)-1-(4-(methylthio)phenyl)but-2-en-1-one (2a)
Method A. 1-(4-(Methylthio)phenyl)ethanone (1a) (1.52 g, 9.1 mmol) was dissolved in dry PhMe (200 mL) and DMADMA (1.3 mL, 9 mmol) was added. Reaction mixture was refluxed for 48 h. Volatile components were evaporated and the product isolated by column chromatography (EtOAc/petroleum ether). Yield: 110 mg (5.1 %), yellow oil. 1 Method B. (E)-3-(dimethylamino)-1-(4-fluorophenyl)but-2-en-1-one (2f) (2 mmol, 412 mg) was dissolved in dry DMF (3 mL) and MeSNa (2 mmol, 140 mg) was added. Reaction mixture was stirred for 24 h at 70 °C. Volatile components were evaporated and the product isolated by column chromatography (EtOAC/petroleum ether = 1:1). Yield: 376 mg (80 %).
1 H NMR is in agreement with 1 H NMR spectra of the product prepared by the method A. (E)-1-(4-Bromophenyl)-3-(dimethylamino)but-2-en-1-one (2e) 29 1-(4-Bromophenyl)ethanone (1e) (4.00 g, 20 mmol) was dissolved in dry PhMe (50 mL) and DMADMA (3.8 mL, 26 mmol) was added. The reaction mixture was refluxed for 3 h and chilled. When petroleum ether was added the product precipitated from the reaction mixture and was recrystallized from EtOAc. 29 1-(4-Fluorophenyl)ethanone (1f) (6.06 mL, 50 mmol) was dissolved in dry PhMe (100 mL) and DMADMA (11.00 mL, 75 mmol) was added to reaction mixture. Reractiom mixture was refluxed for 48 h volatile components were evaporated and the product was isolated by column chromatography (EtOAC/petroleum ether = 1:1). Yield: 6.93 g (67 %), yellow solid. 1 (Z)-3-Amino-1-(4-(methylthio)phenyl)but-2-en-1-one (3a) (E)-3-(Dimethylamino)-1-(4-(methylthio)phenyl)but-2-en-1-one (2a) (108 mg, 0.46 mmol) was dissolved in MeOH (3 mL) NH4OAc (308 mg, 4 mmol) was added and the reaction mixture stirred for 18 h at room temperature. Volatile components were evaporated and the product isolated by column chromatography (EtOAc/petroleum ether = 1:1 (Z)-3-Amino-1-(4-bromophenyl)but-2-en-1-one (3e) (Z)-1-(4-bromophenyl)-3-(dimethylamino)but-2-en-1-one (2e) (2.81 g, 10.5 mmol) was dissolved in MeOH (50 mL) NH4OAc was added (7.7 g, 100 mmol) and the reaction mixture was stirred for 2 h at room temperature. Volatile components were evaporated and the product was isolated by column chromatography (EtOAc/petroleum ether = 1:1 -1-(4-(methylsulfonylphenyl)-1-oxobut-2-en-2-yl) hydrazine-1,2-dicarboxylate (4d) (Z)-3-amino-1-(4-(methylsulfonylphenyl)but-2-en-1-one (3d) (570 mg, 2.38 mmol) was dissolved in MeCN (10 mL) DEAD was added (408 μL, 2.6 mmol) and reaction mixture stirred for 12 h at room temperature Volatile components were evaporated and the product was isolated by column chromatography (EtOAc/petroleum ether = 1:1). Yield: 450 mg (46 %), yellow oil. 1 
(E)-3-(Dimethylamino)-1-(4-(methylsulfonyl)phenyl)but-2-en-1-one (2d)

Diethyl 1-(3-amino-1-(4-bromophenyl)-1-oxobut-2-en-2-yl)hydrazine-1,2-dicarboxylate (4e) (Z)-3-amino-1-(4-bromophenyl)but-2-en-1-one (3e) (670 mg, 2.80 mmol) was dissolved in
MeCN (10 mL) DEAD was added (486 μL, 3.1 mmol) and the reaction mixture was stirred 14 h at room temperature. Volatile components were evaporated and the product was isolated by column chromatography (EtOAc/petroleum ether = 1:1). Yield: 1.00 mg (87 %), yellow oil. 
Ethyl [4-methyl-5-(4-(methylthiobenzoyl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl]carbamate (5a)
(Z)-3-amino-1-(4-(methylthiophenyl)but-2-en-1-one (3a) (93 g, 0.45 mmol) was dissolved in (2 mL) DEAD (80 μL, 0.5 mmol) was added and reaction mixture stirred for 2 h at room temperature. Intermediate diethyl 1-(3-amino-1-(4-(methylthio)phenyl)-1-oxobut-2-en-2-yl)hydrazine-1,2-dicarboxylate (4a) was used directly in the cyclisation step without purification. NaOH (60 mg, 1.5 mmol) was added to the reaction mixture and it was stirred for 48 h at room temperature. Volatile components were evaporated and the product isolated by column chromatography (CHCl3/MeOH = 15:1 
Ethyl [5-(4-chlorobenzoyl)-4-methyl-2-oxo-2,3-dihydro-1H-imidazol-1-yl]carbamate (5c)
(Z)-3-amino-1-(4-chlorophenyl)but-2-en-1-one 30 (3c) (3.74 g, 19.2 mmol) was dissolved in EtOH (50 mL) DEAD (3.57 mL, 22 mmol) was added and the reaction mixture was stirred for 4 h at room temperature. Intermediate diethyl 1-(3-amino-1-(4-chlorophenyl)-1-oxobut-2-en-2-yl)hydrazine-1,2-dicarboxylate (4c) was directly used in next step without isolation. To 4c was added NaOH (1.6 g, 40 mmol) and reaction mixture was stirred for 15 h at room temperature. 
Ethyl [5-(4-bromobenzoyl)-4-methyl-2-oxo-2,3-dihydro-1H-imidazol-1-yl]carbamate (5e)
Diethyl 1-(3-amino-1-(4-bromophenyl)-1-oxobut-2-en-2-yl)hydrazine-1,2-dicarboxylate (4e) (1.00 g, 2.44 mmol) was dissolved in EtOH (10 mL) and NaOH was added (260 mg, 6.5 mmol). Reaction mixture was stirred for 14 h at room temperature and product isolated by column chromatography (CHCl3/MeOH = 10:1 
5-Methyl-4-(4-(methylthio)benzoyl)-1H-imidazol-2(3H)-one or Enoxymone (7a)
Ethyl (4-methyl-5-(4-(methylthio)benzoyl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)carbamate (5a) (95 mg, 0.28 mmol) was dissolved in EtOH (5 mL) KOH was added (220 mg, 3.4 mmol) and the reaction mixture was reflxed for 20 h. Volatile components were evaporated the solid residue dissolved in H2O (1 mL) and concentrated solution of HCl(aq) (3 mL) was added. Reaction mixture was than chilled to 0 °C and 2 M NaNO2(aq) (5 mL) was slowly added during 20 min. When all NaNO2(aq) was added the reaction mixture was stirred further for 20 min at room temperature. White solid precipitated which was filtered and washed with Et2O (3x5 mL 
4-Benzoyl-5-methyl-1H-imidazol-2(3H)-one (7b)
(E)-3-(dimethylamino)-1-phenylbut-2-en-1-one 29 (2b) (3.78 g, 20 mmol) was disolved in MeOH (50 mL) NH4OAc was added (15.4 g, 200 mmol) and the reaction mixture was stirred for 3 h at room temperature. Volatile components were evaporated and the product, (Z)-3-amino-1-phenylbut-2-en-1-one, 30 was isolated by column chromatography (EtOAc/petroleum ether = 1:1) and used directly in the next step. EtOH (50 mL) and DEAD was added (2.98 mL, 19.0 mmol) and the reaction mixture was stirred 14 h at room temperature when NaOH (1.90 g, 47.5 mmol) was added. The reaction mixture was stirred further for 24 h. Precipitated product was used directly in the next step. Ethyl (5-benzoyl-4-methyl-2-oxo-2,3-dihydro-1H-imidazol-1-yl)carbamate (5b) (662 mg, 2.3 mmol) was dissolved in the mixture of H2O/THF = 1:1 (20 mL) and KOH was added to solution (560 mg, 10 mmol). The reaction mixture was refluxed for 24 h, volatile components were evaporated and intermediate 1-amino-5-benzoyl-4-methyl-1H-imidazol-2(3H)-one (6b) was isolated by column chromatography (CHCl3/MeOH = 7:1). Intermediate 6a was suspended in H2O (10 mL) and HCl(aq) (2 mL) was added to a suspension. Reaction mixture was chilled to 0 °C and 1.5 M solution of NaNO2(aq) (8 mL) was added during 30 minutes. Reaction mixture was than stirred for 2 h at room temperature. Volatile components were evaporated and the product was isolated using Soxhlet's extraction (EtOAc 
4-(4-Chlorobenzoyl)-5-methyl-1H-imidazol-2(3H)-one (7c)
Ethyl (5-(4-chlorobenzoyl)-4-methyl-2-oxo-2,3-dihydro-1H-imidazol-1-yl)carbamate (5c) (1.62 g, 5 mmol) was dissolved in EtOH (20 mL) KOH was added (3.00 g, 53.5 mmol) and the reaction mixture was refluxed for 15 h. Volatile components were evaporated, solid residue dissolved in H2O (5 mL) and concentrated HCl(aq) (3 mL) was added. Reaction mixture was than chilled to 0 °C and 6 M NaNO2(aq) (5 mL) was slowly added during 20 min. When all NaNO2(aq) was added the reaction mixture was stirred further for 20 min at room temperature. White solid precipitated which was filtered and washed with Et2O (3x5 mL 
4-(4-Bromobenzoyl)-5-methyl-1H-imidazol-2(3H)-one (7e)
Ethyl (5-(4-bromobenzoyl)-4-methyl-2-oxo-2,3-dihydro-1H-imidazol-1-yl)carbamate (5e) (421.5 mg, 1.5 mmol) was dissolver in EtOH (5 mL) KOH was added (1.00 g, 17.85 mmol) and reaction mixture refluxed for 12 h. Volatile components were evaporated the solid residue dissolved in H2O (5 mL) and concentrated solution of HCl(aq) (2 mL) was added. Reaction mixture was than chilled to 0 °C and 6 M NaNO2(aq) (5 mL) was slowly added during 20 min. When all NaNO2(aq) was added the reaction mixture was stirred further for 20 min at room temperature. White solid precipitated which was filtered and washed with Et2O (3x5 mL 
